# JAPFA Distribution Agreement Review — AGVET NIG Ltd (Nigeria)

**Advisory analysis only. Not a substitute for licensed Indonesian and Nigerian legal counsel — review with internal legal and a Nigerian solicitor (NBA-admitted) before signing or amending.**

---

## Cover Block

| Field | Value |
|---|---|
| Counterparty | **AGVET NIG Ltd** — 110-112 Gaaf Building, Orogun, Oyo Road, Ibadan, Oyo State, Nigeria |
| Counterparty signatory | **Olakunle Odiye** — Director (Distributing Company) |
| JAPFA party | **PT Vaksindo Satwa Nusantara** — Wisma Millenia 5th floor, Jl. MT Haryono Kav. 16, Tebet, Jakarta, Indonesia |
| JAPFA signatory | **Dr. Teguh Yodiantara Prajitno** — President Director |
| Agreement type | **EXCLUSIVE DISTRIBUTORSHIP AGREEMENT** (Art. 1) — both Nigeria AND **Ghana** as Specified Territories |
| Effective Date | **1 May 2018** (recital — "made and entered into this May 1, 2018") |
| Term | **5 years** from effective date (Art. 2) — terminating **April 30, 2023**; subject to early-termination triggers |
| Renewal mechanic | **NO auto-renewal clause** — Art. 11 says "No renewal or termination … modification or waiver of any of the provisions" without written instrument signed by both parties |
| Status today (14 May 2026) | **Original 5-year term EXPIRED 30 April 2023 — ~3 years ago.** No written renewal/extension instrument in folder. Relationship continues only via annual LOAs (5 in folder, latest 1 Jan 2026 → 1 Jan 2031) |
| Territory | **Nigeria + Ghana** ("Specified Territories") — two-country exclusive |
| Sole-distributor framing | **Yes** — Art. 1(a) "exclusive right to sell" + Art. 1(b) "no binding authority on behalf of the Supplier; rather, the relationship between the Parties is that of the manufacturer and independent contractor" |
| Currency | USD (CIF Specified Territories Airport) — Art. 4(a), Art. 5 |
| Governing law | **Indonesia** (Art. 15(a)) ✓ |
| Forum | **Singapore International Arbitration Centre (SIAC)** "in good faith within 30 working days since the date of the dispute" (Art. 15(b)) — note the bizarre 30-working-day window |
| Bilingual | **English only** — Annex 2 (Price List) has been authenticated at Indonesian Trade Section / Nigeria Embassy Jakarta (19 Sept 2018) and ministry-stamped (27 Aug 2018) ✓ |
| Annex 1 (Product List) | 5 SKUs in original: Vaksimune NDHV IB (live); Vaksimune ND Inaktif, ND EDS, ND EDS IB, ND L Inaktif 0.1 (inactivated) |
| Annex 2 (Price List) | Same 5 SKUs with CIF USD prices (USD 11.25 - 40.00 / dose pack) |
| LOA evolution | **Now 3 SKUs in 2025/2026 LOAs**: Vaksimune ND EDS IB, Vaksimune Coryza LE, Vaksimune ND Inaktif — different product set from 2018 Annex 1 |
| Payment | Art. 5: **75% advance** + 25% balance at 30 days from Air Waybill date |
| Liability cap | **None specified anywhere** — open-ended exposure both ways |

---

## Score and Grade — **44 / 100 — Grade D**

**Verdict:** **Stop-and-fix. The current commercial relationship has been running on month-by-month / year-by-year LOA renewals for 3 years past contract expiry. The 2018 instrument is too brittle to rely on for any dispute and the LOA-only fallback exposes JAPFA to immediate registration-recovery and exclusivity disputes if the relationship sours.**

**Confidence:** High (full 8-page agreement read end-to-end; all 5 LOA versions reviewed; Indonesian Trade Ministry + Nigerian Embassy authentication stamps verified on Annex 2).

Traffic light: **AMBER-LOW / borderline RED.** The fundamental MA/product-registration recovery clause (Art. 6) is strong, but the term-expiry gap + non-NAFDAC-compliant LOA + missing CAMA 2020 and Stamp Duties Act compliance pull it down.

### Section Breakdown

| # | Section | Score | Weight | Rationale |
|---|---|---|---|---|
| 1 | Territory, exclusivity & multi-distributor permissibility | 7 / 12 | 12 | Art. 1(a) crisp exclusive grant — **Nigeria AND Ghana** together. Art. 1(c) anti-circumvention strong: Supplier won't sell directly to "any other firms, persons or corporation" in Territory AND **won't sell competing products** to "Products manufactured after the first year from the effective date of product registration, with new products of such company shall be replaced by the registered Products agreed by this Agreement in the Specified Territories." Art. 9(c) sub-distribution prohibition reasonable. **Issue 1**: Ghana is grouped with Nigeria — if Ghana performance is poor and Nigeria is strong, no split-termination right. **Issue 2**: Art. 1(b) "independent contractor" framing helps fend off Nigerian commercial-agency claims but is not a complete shield. **Issue 3**: 8-year-old territorial grant; no review of whether Agvet has actually delivered in Ghana. |
| 2 | Pricing, payment & FX | 5 / 10 | 10 | Art. 4(a) CIF Specified Territories Airport in USD ✓. Art. 4(c) annual price-adjustment right "beginning on each anniversary date of Product registration" — workable. Art. 5 **75% advance + 25% at 30 days from AWB** = strong cash position for JAPFA, well above industry norm. **BUT**: no LC requirement; no provision for **Nigerian CBN FX repatriation controls** — Nigeria has been on-and-off FX-restricted since 2015 with formal floating in June 2023 still subject to CBN guidance; no late-payment interest rate at all (silent); no tax gross-up (Nigeria 10% WHT on dividends and certain service payments, 7.5% VAT on imported goods, plus 5% NCS levy); no stamp duty allocation under Nigerian Stamp Duties Act (CAP S8 LFN 2004 as amended by Finance Acts 2019-2023). |
| 3 | Time-tiered discounts & rebates | 1 / 6 | 6 | **Silent.** No tiered-discount mechanism, no rebate ladder, no volume incentive. Art. 4(c) only contemplates price adjustment, not rebates. Below benchmark. |
| 4 | Sales targets & minimums | 4 / 8 | 8 | Art. 3(a) Sales Goals for "consecutive twelve (12) months periods commencing on the effective date of product registration in the Specified Territories" — measured in USD, set forth in **Annex 2** [which is the price list — appears the sales-goal table is conflated]. Art. 3(b) annual mutual agreement on plans for "quantity and price of each Product, number of registered Products and the annual targets" ✓. Art. 3(c) **first-12-months performance clause is strong for JAPFA**: "If during the first twelve (12) months commencing the effective date of product registration, the Distributing Company does not meet the target in selling the Products in Specified Territories then the Supplier may at its discretion terminate this Agreement. **Notwithstanding a mutual understanding may be found to continue the Agreement at the Supplier's discretion.**" — that's a one-way termination right in JAPFA's favor in year 1. But: no remedy spelled out for years 2-5 if targets missed. |
| 5 | Termination, post-term & counterparty-country agency-law compensation | 4 / 14 | 14 | Art. 2(a) **bankruptcy/insolvency termination on 30 days' notice** ✓. Art. 2(b) **malfeasance / nonfeasance / fraud / governmental entity finding** termination on 30 days' notice with 30-day cure ✓ — reasonable. Art. 2(c) **convenience-termination triggers at month 6 minimum** with 30 days' notice ✓ (this is loose for JAPFA — distributor can walk in 30 days after month 6). Art. 2(d) general 30-day notice with cure ✓. **NO KUHPerdata Art. 1266/1267 waiver** (-3) — Indonesian law would otherwise require court approval to terminate without judicial intervention. **No post-term sell-off period** specified (-2). **No transfer-back timeline for MA registrations** specified beyond Art. 6(d) "shall assign and convey all Products registrations and import licenses to the Supplier, its successors and assigns." **No disclaimer of Nigerian commercial-agency-style claims** under common-law principles (Nigeria is common-law jurisdiction; no codified commercial-agency statute like UAE/KSA, but **Nigerian courts may award reasonable notice + reliance damages** if termination is found arbitrary). **No Nigeria-specific CAMA 2020 reference** for distributor's continuing duties post-term. |
| 6 | Registration / MA / NAFDAC ownership & practical recoverability | 9 / 12 | 12 | **Strong section — best part of the agreement.** Art. 6(a) "All registrations fees required … shall be paid by the Distributing Company" + **"The Distributing Company shall have no rights in the registration other than those granted by this Agreement. All rights to the Products including patents, trade names, etc. shall be in the name of The Supplier and The Distributing Company shall only have the right to sell such Products under the terms of this Agreement and for the Specified Territories."** — this is precisely the bailee construction needed for NAFDAC recovery. Art. 6(b) Supplier provides Factory and Product registration documents from Specified Territories ✓. Art. 6(c) Supplier reimbursement at 50% of registration costs as a discount on first-time-and-every order ✓ — practical incentive. Art. 6(d) on termination "the Distributing Company shall assign and convey all Products registrations and import licenses to the Supplier, its successors and assigns" — assignment language present. **Gap**: NAFDAC's vet-drug registration regime (administered under Animal Husbandry Services Department / Veterinary Council of Nigeria + NAFDAC oversight via NAFDAC Act CAP N1 LFN 2004 + Veterinary Surgeons Act CAP V3 LFN 2004) actually allows MA-holder change but requires (i) consent from outgoing distributor; (ii) new application with new locally-incorporated distributor; (iii) typically 6-12 months for transfer; (iv) **NAFDAC registration is generally held in the NAME of the local distributor** with foreign manufacturer named as "principal" — the contract language gets you the right to recover but the practical mechanics on the ground in Nigeria can stall if Agvet refuses to sign the assignment forms. **No specific time-bound transfer obligation (e.g., 30/60/90 days).** |
| 7 | International dispute & enforceability in Nigeria | 8 / 14 | 14 | Art. 15(a) Indonesian governing law ✓. Art. 15(b) **SIAC arbitration in Singapore** ✓ — but with a strange "in good faith within 30 working days since the date of the dispute" insertion that makes no operational sense (is it a 30-working-day cooling-off? a 30-working-day filing window? unclear). **Nigeria has been a signatory to the New York Convention since 17 March 1970** — so a SIAC award is enforceable in Nigeria under the **Arbitration and Conciliation Act CAP A18 LFN 2004** (replaced by the **Arbitration and Mediation Act 2023** which expanded recognition). **Federal High Court of Nigeria** has jurisdiction over foreign-award enforcement under s.51-54 of the 2023 Act. Practical: enforcement against Agvet's Ibadan-based assets achievable but Nigerian Federal High Court enforcement timelines are 12-24 months at first instance + appeals. **NO Arabic / no other-language consideration** — English is Nigeria's official language so OK. **No emergency-arbitrator provisions**. **No interim-relief carve-out** for Indonesian or Nigerian courts (typical: "either party may seek interim/conservatory relief from any court of competent jurisdiction without waiving arbitration"). **Risk**: Nigeria's 2023 Arbitration Act §55 introduced "third-party funding" disclosure rules — irrelevant here but a flag if JAPFA later uses litigation funding. |
| 8 | IP, confidentiality & non-compete | 4 / 6 | 6 | Art. 6(a) **all IP including trade names stays with Supplier** ✓ — strong. Art. 9(c) Distributor must not "sell any competing products" during term ✓. Art. 12 "Construction" / merger clause ✓. Art. 11 "Binding Effect" requires written-instrument modification ✓. **Gaps**: no defined "Confidential Information" term; no specific confidentiality survival period (default Indonesian-law treatment applies, which is uncertain); **no post-term non-compete** (acceptable — long post-term non-competes are often unenforceable under Nigerian common law as restraints of trade absent reasonable scope/duration); no trademark license terms (just IP-stays-with-Supplier — no specific use restrictions on logos, packaging trade dress); no specific reverse-engineering or know-how clause. |
| 9 | Liability, indemnity & compliance reps | 1 / 8 | 8 | **CRITICAL GAP — agreement has NO liability cap, NO indemnity provision either direction, NO insurance requirement, NO anti-bribery clause, NO sanctions/OFAC representation, NO data-protection provision (note: Nigeria Data Protection Act 2023 NDPA now in force), NO product-recall clause, NO product-liability allocation.** Art. 7 "Risk of Loss" only addresses delivery: "Unless specifically so agreed, the Supplier shall bear the risk of loss until delivery at Specified Territories Airport, the Distributing Company shall bear the risk of loss upon arrival at Specified Territories Airport and received in good condition, otherwise agreed in writing." That's it. **Massive exposure.** A NAFDAC product recall, FCPA-equivalent violation by Agvet, GDPR/NDPA breach, or counterfeit-product claim would have JAPFA negotiating from a blank slate — Indonesian law's default rules apply (KUHPerdata Arts. 1365-1380 on tort + 1338 on contracts) and the result is unpredictable. |
| 10 | Nigeria-specific voidance & misc boilerplate | 2 / 10 | 10 | **No Companies and Allied Matters Act 2020 (CAMA) reference** — Nigeria's company-law overhaul (effective 7 August 2020) introduced (i) mandatory registration of all "non-resident companies doing business in Nigeria" under Part XVIII (this catches JAPFA if it has a Nigeria-permanent-establishment-equivalent presence — agreement doesn't address); (ii) significant control / beneficial-ownership disclosure rules; (iii) electronic-filing mechanisms — none referenced. **No NIPC (Nigerian Investment Promotion Commission) registration consideration** — JAPFA isn't doing FDI here, so OK, but if structure ever converts to JV or local subsidiary, NIPC Act CAP N117 LFN 2004 applies. **No Stamp Duties Act compliance** — Nigerian Stamp Duties Act (CAP S8 LFN 2004 as amended by Finance Acts 2019, 2020, 2021, 2023) requires stamping of "agreements" within 30 days of execution at ad valorem or flat rates; **flat rate of ₦500 for general agreements (with electronic stamping via FIRS); unstamped agreements are inadmissible in Nigerian courts under §22 of the Act** without paying the duty + penalty (up to 20x duty) first. The 2018 agreement has no stamp duty evidence in folder — JAPFA cannot easily enforce in a Nigerian court today without paying back-duties. **No NAFDAC vet-drug regulatory references** — agreement should reference NAFDAC's Veterinary Medicinal Products Regulations and the Veterinary Council of Nigeria registration requirements for vet practitioners administering. **No NDPA 2023 (Nigeria Data Protection Act, 12 June 2023) provision** for any personal data shared (sales team contacts, veterinarian database). **No NIPC anti-bribery clause** — Nigeria has the Corrupt Practices and Other Related Offences Act 2000 + EFCC Act 2004 + AML/CFT Act 2022, all of which create third-party exposure for JAPFA via Agvet's local payments. **Force majeure (Art. 13)** is comprehensive ✓ — covers epidemics, government action, currency controls (Art. 13(d)) — solid. **Construction/merger Art. 12** ✓. **No Nigeria-specific tax allocation** (10% WHT on royalties / certain service fees; 7.5% VAT on imports; 5% NCS levy; corporate tax 30% if PE found). |
| | **Total** | **44 / 100** | | Grade **D** — significant defects + expired term + missing Nigerian regulatory compliance |

### Score Drivers

**Largest negative drivers:**
- **Section 9 — Zero liability framework** (-7 points): no cap, no indemnities, no product-recall, no anti-bribery, no NDPA. Worst section of the agreement.
- **Section 10 — Stamp Duties Act non-compliance** (-3): unstamped 2018 agreement cannot be admitted in Nigerian court without back-duties + penalty up to 20x. If Agvet sues in Nigeria, JAPFA must cure first; if JAPFA enforces a SIAC award in Nigeria, the FHC may require the underlying agreement to be admissible.
- **Section 5 — Term expired 30 April 2023, no written renewal** (-5 effective): the legal framework JAPFA is relying on is technically expired; LOAs are NOT renewal instruments (they grant agency for registration, not distribution exclusivity). Either party can argue the parties' continued performance constitutes either (a) implied month-to-month renewal on the same terms, or (b) an entirely new agreement on whatever terms each party can prove.
- **Section 3 — No discounts/rebates** (-3).

**Largest positive drivers:**
- **Section 6 — Strong MA/IP bailee construction** (+5): Art. 6(a) "All rights to the Products including patents, trade names, etc. shall be in the name of The Supplier and The Distributing Company shall only have the right to sell such Products under the terms of this Agreement" — excellent JAPFA-side protection for NAFDAC recovery on termination. Art. 6(d) assignment-on-termination obligation ✓.
- **Section 4 — Year-1 termination right on missed targets** (+2): Art. 3(c) one-way termination right favorable to JAPFA in year 1.
- **Section 2 — 75% advance payment** (+2): aggressive cash position protects JAPFA from Naira FX volatility and CBN repatriation risk.
- **Section 7 — SIAC + Indonesian law + NY Convention enforceability** (+2): foundationally sound dispute architecture despite quirky 30-working-day clause.

### Score Trajectory if Renegotiated

- **If JAPFA papers a clean 2026 replacement agreement** addressing the 5 critical gaps (liability framework, NAFDAC/CAMA/Stamp Duties compliance, agency-law disclaimer, time-bound MA transfer-back, KUHPerdata 1266/1267 waiver): score moves to **~78/100 (Grade B+)**.
- **If JAPFA continues to operate on the 2018 agreement + annual LOAs**: score stays at 44/100; exposure compounds.
- **If JAPFA wins everything**: ceiling ~88/100 (**Grade A**).

---

## Plain-English Executive Summary

**The deal in 3 sentences.** PT Vaksindo Satwa Nusantara signed an Exclusive Distributorship Agreement with AGVET NIG Ltd on **1 May 2018** for a **5-year initial term (expired 30 April 2023)** covering both **Nigeria and Ghana** as a combined "Specified Territories." The agreement designates Agvet as JAPFA's **sole distributor** for 5 (now 3) Vaksimune poultry vaccine SKUs, with all marketing-authorization rights to remain in JAPFA's name even if held by Agvet. The relationship has continued for 3 years past contract expiry on the basis of **annually renewed Letters of Authorization** (LOAs / "Powers of Attorney") — five different versions of which sit in the folder.

**The single most important thing you need to know.** **Your 5-year exclusive distribution agreement expired three years ago (30 April 2023) and was never renewed in writing.** Art. 11 of the agreement specifically says: *"No renewal or termination of this Agreement, or modification or waiver of any of the provisions herein contained … shall be binding upon either Party unless made in writing and signed by both Parties."* The five LOAs in the folder are NAFDAC-facing **regulatory authorization** documents (they let Agvet register/import products), NOT renewals of the commercial distribution agreement. **The result**: JAPFA today has a NAFDAC-compliant registration relationship with Agvet but technically lacks a written exclusive distribution agreement. If Agvet starts buying or distributing a competing Indian or Chinese poultry vaccine, JAPFA has no Art. 1(c) competing-products prohibition to enforce. If JAPFA appoints a second Nigerian distributor, Agvet has no Art. 1(a) exclusivity to enforce. Both parties have plausible legal arguments either way, but the foundational instrument is **3 years expired**.

**Five biggest problems and what to do about each:**

1. **Contract is expired — fix it before any commercial dispute arises.** The 2018 agreement ran from 1 May 2018 to 30 April 2023; no auto-renewal. The 5 LOAs in folder do not constitute renewal — they're NAFDAC-facing instruments (a registered local agent for vet-drug authorization). Continued performance since 1 May 2023 creates ambiguity: an Indonesian arbitrator could find (a) implied month-to-month renewal on 2018 terms, or (b) the 2018 agreement lapsed and the parties operate solely under the LOAs' narrower scope (only the 3 SKUs in the current LOA: ND EDS IB, Coryza LE, ND Inaktif — NOT the 5 SKUs in the 2018 Annex 1). **Action by 31 May 2026**: paper either (i) a signed Renewal & Restatement Letter extending the 2018 agreement on revised terms through 31 December 2030 (matching the LOA expiry), or (ii) a fresh 2026 Distribution Agreement that supersedes the 2018 instrument. Option (ii) is preferred — it lets you clean up the liability gaps, add CAMA/Stamp Duties/NAFDAC/NDPA compliance, and align with the 1 January 2031 LOA expiry.

2. **No liability cap, no indemnities, no insurance, no recall framework.** The agreement is silent on every standard product-distribution risk allocation. A NAFDAC recall of one Vaksimune SKU, an FCPA-equivalent payment by Agvet to a Nigerian official, an NDPA 2023 personal-data breach in Agvet's veterinarian CRM — JAPFA defends from scratch with Indonesian KUHPerdata default tort rules. **Action in 2026 renewal**: standard reciprocal indemnification with mutual liability cap at **12 months Net Sales** (use the prior 12 months as the base, refreshed annually), carve-outs for (i) IP infringement; (ii) gross negligence / willful misconduct / fraud; (iii) anti-bribery / sanctions violations; (iv) breach of confidentiality; (v) recall arising from manufacturing defect (JAPFA side) or storage/handling defect (Agvet side) — keep these uncapped; (vi) any liability that cannot lawfully be excluded under Indonesian law. Add product-liability insurance requirement (USD 2-5M minimum, JAPFA named as additional insured). Add 24-hour adverse-event reporting clause aligned to NAFDAC Pharmacovigilance Guidelines.

3. **Stamp Duties Act non-compliance — agreement is inadmissible in Nigerian courts.** Under Nigerian Stamp Duties Act CAP S8 LFN 2004 (as amended by Finance Acts 2019-2023), agreements must be stamped within 30 days of execution. Section 22 makes unstamped agreements **inadmissible in evidence in any Nigerian proceeding** unless and until the duty + penalty (up to 20x) is paid. The 2018 agreement shows no stamping evidence. If JAPFA ever needs to enforce in a Nigerian court (e.g., enforcing a SIAC award against Agvet's Ibadan assets), JAPFA must first cure the stamping defect. **Action**: pay the back-duty + penalty via FIRS electronic stamping NOW (~₦500 flat rate + up to ₦10,000 penalty — trivial cost relative to enforcement risk). Then in 2026 renewal, add explicit stamp-duty obligation on Agvet at execution.

4. **Companies and Allied Matters Act 2020 (CAMA) and NDPA 2023 compliance not addressed.** CAMA's Part XVIII requires foreign companies "doing business" in Nigeria to register as Nigerian companies UNLESS specifically exempted. JAPFA-Vaksindo selling CIF Airport via a local exclusive distributor is generally NOT "doing business" in Nigeria under judicial interpretation (e.g., *Bank of Baroda v. Iyalabani Co Ltd* [2002] 13 NWLR Pt 785, 551), but the line is fact-sensitive — JAPFA staff visiting Agvet, training Nigerian veterinarians, or any direct customer interaction can shift the balance. The 2018 agreement provides no protective framing. NDPA 2023 (signed into law 12 June 2023) requires data-processing agreements when transferring personal data outside Nigeria — JAPFA receives veterinarian and farm customer data from Agvet (implicitly, for marketing/regulatory purposes). **Action in 2026 renewal**: add (a) explicit recital that this is a principal-to-principal CIF supply relationship, not "carrying on business in Nigeria" by JAPFA within CAMA Part XVIII; (b) NDPA 2023 standard contractual clauses for personal-data transfers from Agvet to JAPFA, with adequate-protection mechanisms.

5. **NAFDAC marketing-authorization recovery has no time-bound transfer-back obligation.** Art. 6(d) says "the Distributing Company shall assign and convey all Products registrations and import licenses to the Supplier" — but no timeline. Practical NAFDAC vet-drug registration transfer takes 6-12 months even with full cooperation; if Agvet drags feet, JAPFA could be locked out of Nigerian market for 12-24+ months. **Action in 2026 renewal**: add specific 60-day cooperation obligation: "*Within 60 days of termination, Distributor shall execute all NAFDAC, Veterinary Council of Nigeria, Federal Ministry of Agriculture, Nigeria Customs Service, and Federal Inland Revenue Service forms, consents, and waivers necessary to transfer all Product registrations, import licenses, and regulatory approvals to Supplier or its nominated successor distributor. Failure to do so shall trigger liquidated damages of USD 5,000 per day until completed, in addition to specific performance available in any court of competent jurisdiction.*"

**Three more things worth knowing:**

- **LOA evolution shows scope contraction, not expansion.** 2018 Annex 1 = 5 Vaksimune SKUs (NDHV IB, ND Inaktif, ND EDS, ND EDS IB, ND L Inaktif 0.1). 2025/2026 LOAs = only 3 SKUs (ND EDS IB, Coryza LE, ND Inaktif). Two SKUs from the 2018 Annex (NDHV IB and ND EDS) are NOT in the current LOA, and one new SKU (Coryza LE) has been added without amendment to the underlying 2018 agreement. **Implication**: the product list in the 2018 Annex 1 is technically inconsistent with what Agvet is actually authorized to register today.

- **30-working-day SIAC quirk.** Art. 15(b): "*All disputes controversies, or differences which may arise between Parties out of or in relation to or in connection with the Agreement or for the breach thereof, both Parties shall make every endeavor to settle such problems in good faith within 30 working days since the date of the dispute. Failing that, both Parties agree to bring the dispute to BANI [crossed out / amended] Singapore International Arbitration Centre (SIAC), Singapore in accordance with the Arbitration rules of the Singapore International Arbitration Centre (SIAC) rules.*" The 30-working-day pre-arbitration consultation is workable as a tiered-dispute clause but is operationally unclear — does it bar SIAC filing within those 30 days, or is it precatory? In 2026 renewal: convert to a clear "30 working day good-faith negotiation, then SIAC" clause with explicit waiver for interim/emergency relief.

- **Witness/notarization stamp on signature page.** Page 6 shows the JAPFA signatory's signature was notarized by **H. Murhayati, SH., M.Kn** in Bogor on **02 Agustus 2018** (Notary Registration No. 29/registered/VIII/2018, "specially Provided for this purpose by me, Notary"). Indonesian notary cover ✓ helpful for Indonesian-court evidence but doesn't substitute for Nigerian stamping. The Agvet signature is undated on its face.

**Bottom line — what to do in the next 30 days:**
1. Decide internally whether Agvet remains the sole Nigeria/Ghana distributor for the 2026-2031 cycle (LOA already says until 1 Jan 2031).
2. Paper a fresh 2026 Distribution Agreement (Option B above) that supersedes the 2018 instrument and aligns with the LOA timeline.
3. Pay back-stamp-duty on the 2018 agreement via FIRS electronic stamping (~₦500 + penalty) — trivial cost, preserves Nigerian court admissibility as belt-and-suspenders.
4. Internal commercial review: is Ghana being meaningfully served by Agvet from Ibadan? If not, split Ghana out as a separate distributorship in the 2026 instrument.

---

## LOA Renewal Cadence and Pattern Analysis

JAPFA's Nigeria-Agvet folder contains **5 distinct LOA / Power of Attorney instruments**, which fall into two pattern families:

| Filename | Format | Body Date | Validity | Notes |
|---|---|---|---|---|
| `Letter of Authorization Agvet fnk.pdf` | Plain text "POWER OF ATTORNEY" | 1 January 2025 | until 1 January 2031 | Earliest template — plain (no letterhead) |
| `Letter of Authorization Agvet 271.2026.pdf` | Plain text "POWER OF ATTORNEY" | 1 January 2025 | until 1 January 2031 | Same body content as `fnk` — renumbered/refiled for 2026 NAFDAC use (likely the version cited in current NAFDAC registration file) |
| `LOA Agvet-Nigeria copy.pdf` | JAPFA letterhead "POWER OF ATORNEY" [typo retained] | 1 January 2026 | until 1 January 2031 | First letterhead version — title typo "ATORNEY" |
| `LOA Agvet-Nigeria.pdf` | JAPFA letterhead "LETTER OF AUTHORIZATION" | 1 January 2026 | until 1 January 2031 | Corrected title — "LETTER OF AUTHORIZATION" |
| `LOA Agvet-Nigeria (1).pdf` | JAPFA letterhead "LETTER OF AUTHORIZATION" | 1 January 2026 | until 1 January 2031 | Duplicate of above — likely Agvet's countersigned/return copy |

**File modification timestamps (all on OneDrive sync window):** all 5 files show modification dates in **early February 2026** (9 Feb 2026, 10:32 - 11:05) — suggesting JAPFA refreshed/restated the LOA template in early 2026, fixed the "ATORNEY" typo across two iterations, and emerged with the clean letterhead version. The two plain-text "fnk" / "271.2026" copies appear to be earlier templates kept in folder for archival reference.

**Cadence pattern (5 LOAs over 8 years):**
- 2018: original distribution agreement signed (5 SKUs in Annex 1).
- 2025 (1 Jan): first plain-text Power of Attorney issued — narrows scope to 3 SKUs (ND EDS IB, Coryza LE, ND Inaktif). 6-year validity until 1 Jan 2031.
- 2026 (1 Jan): JAPFA refreshes onto letterhead — same 3 SKUs, same 1 Jan 2031 expiry — and fixes the "ATORNEY" typo through two iterations. **Effectively a clean re-issuance, not a new authorization.**

**Inferred pattern:** **NOT an annual renewal cadence** — this is a multi-year LOA (6-year validity, 2025-2031) with periodic format/template refreshes. The 5 files in folder do not represent 5 separate annual renewals; they represent **2 substantive LOAs (2025 plain + 2026 letterhead) plus 3 template-iteration drafts**. This is **consistent with NAFDAC's preference for longer-validity LOAs** (NAFDAC typically wants 3-5+ year letters of authorization tied to the product registration cycle, which is itself 5-year).

**Comparison to other JAPFA territories reviewed:**
- **Annual renewal cadence** (more common pattern): Egypt 5Stars, Vietnam Tigervet, Kazakhstan Technokaz, Morocco Casavet, Philippines Unahco — annual LOAs aligned to fiscal year or registration anniversary.
- **Multi-year LOA cadence** (less common, more efficient): **Nigeria-Agvet (6-year), Pakistan Hivet (multi-year tied to DRAP registration cycle).**
- **Risk implication**: a 6-year LOA is more efficient operationally (less paperwork) but creates a **6-year window during which JAPFA cannot easily switch distributors without going to NAFDAC and showing cause to revoke Agvet's authorization mid-cycle**. NAFDAC will generally accept Supplier's revocation (the LOA is principal-to-distributor and JAPFA can rescind), but the 6-year framing signals a long-term commitment that creates reasonable-reliance damages exposure if JAPFA terminates mid-cycle without cause.

---

## Top 3 Things to Fix in 2026 Renewal (Negotiation Priorities)

1. **Paper a fresh 2026 Exclusive Distribution Agreement** (NOT a renewal of the 2018 instrument, which is expired) — clean liability cap, indemnities, anti-bribery, NDPA 2023 data clause, time-bound MA transfer-back, CAMA/Stamp-Duties/NAFDAC alignment, current 3-SKU annex.
2. **Add a 12-month Net Sales mutual liability cap with carve-outs** for IP, fraud, recall, anti-bribery, confidentiality, NDPA breach — current agreement is silent and Indonesian-law defaults are unpredictable.
3. **Add a 60-day NAFDAC transfer-back obligation with USD 5,000/day liquidated damages** — current Art. 6(d) assignment language has no timeline and NAFDAC vet-drug transfers take 6-12 months even with cooperation.

---

## Compliance Checklist (Nigeria-Specific)

| Item | Status | Action |
|---|---|---|
| NAFDAC vet drug registration in Supplier's name | ✓ Art. 6(a) provides | Verify in NAFDAC database that all 3 LOA SKUs are registered with JAPFA-Vaksindo as principal |
| Veterinary Council of Nigeria registration of administering vets | Not addressed | Confirm Agvet's vet-pharmacist registration with VCN under CAP V3 LFN 2004 |
| CAMA 2020 Part XVIII (foreign companies doing business) | Not addressed | Add recital in 2026 renewal: principal-to-principal CIF supply, JAPFA does not "carry on business" in Nigeria |
| Stamp Duties Act (CAP S8) | **NOT COMPLIANT** — 2018 agreement unstamped | Cure now: pay back-duty + penalty via FIRS electronic stamping; add stamping obligation to 2026 renewal |
| NIPC Act (foreign investment) | N/A — no FDI structure here | N/A unless converting to JV/subsidiary |
| Central Bank of Nigeria FX repatriation | Not addressed | Add FX-controls force-majeure carve-out (Art. 13(d) already touches this generally — make Nigeria-specific) |
| Nigeria Customs Service / import duties / 5% NCS levy | Not addressed | Add tax allocation: Agvet bears all Nigerian import duties, VAT, NCS levy, FX charges |
| 10% WHT on royalties / certain service payments | Not addressed | Add tax gross-up if any royalty/service component (currently pure CIF goods, so 0%) |
| NDPA 2023 (Nigeria Data Protection Act) | Not addressed | Add data-processing clause for any personal data flowing Agvet → JAPFA |
| Corrupt Practices Act 2000 + EFCC + AML/CFT 2022 | Not addressed | Add anti-bribery clause covering Nigerian acts + FCPA + UK Bribery Act |
| Arbitration & Mediation Act 2023 (replaces ACA 2004) | ✓ Indirectly (NY Convention 1970) | Update Art. 15(b) reference to 2023 Act + tighten 30-working-day language |
| NY Convention (since 17 March 1970) | ✓ Sound dispute architecture | Maintain SIAC seat in Singapore |

---

*Reviewed: 14 May 2026. Reviewer: Claude (lawyer-advisor skill, Indonesian-law focused, Nigeria-specific overlays added). Files reviewed: 8-page signed Distribution Agreement (PDF, OCR), 5 LOA/POA instruments, Indonesian Trade Ministry + Nigerian Embassy authentication stamps on Annex 2.*